0001562180-23-004067.txt : 20230511
0001562180-23-004067.hdr.sgml : 20230511
20230511135312
ACCESSION NUMBER: 0001562180-23-004067
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230509
FILED AS OF DATE: 20230511
DATE AS OF CHANGE: 20230511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Green Eric Mark
CENTRAL INDEX KEY: 0001336007
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-08036
FILM NUMBER: 23910283
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WEST PHARMACEUTICAL SERVICES INC
CENTRAL INDEX KEY: 0000105770
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 231210010
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 6105942900
MAIL ADDRESS:
STREET 1: 530 HERMAN O. WEST DRIVE
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: WEST CO INC
DATE OF NAME CHANGE: 19990405
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-05-09
false
0000105770
WEST PHARMACEUTICAL SERVICES INC
WST
0001336007
Green Eric Mark
530 HERMAN O. WEST DRIVE
EXTON
PA
19341
true
true
false
false
President & CEO
false
Common Stock
2023-05-09
4
M
false
50000.00
57.38
A
178574.0865
D
Common Stock
2023-05-09
4
S
false
14157.00
361.9468
D
164417.0865
D
Common Stock
2023-05-09
4
S
false
12562.00
362.9267
D
151855.0865
D
Common Stock
2023-05-09
4
S
false
12648.00
363.9354
D
139207.0865
D
Common Stock
2023-05-09
4
S
false
4133.00
364.7645
D
135074.0865
D
Common Stock
2023-05-09
4
S
false
500.00
365.458
D
134574.0865
D
Stock Option (Right to Buy)
57.38
2023-05-09
4
M
false
50000.00
0.00
D
2025-04-24
Common Stock
50000.00
148132.00
D
The shares reported were acquired by the Reporting Person from exercising a portion of a stock option award expiring in 2025, pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 9/14/2022.
This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on 9/14/2022. The Rule 10b5-1 trading plan, which was structured to include several sale periods, was established as part of the Reporting Person's long-term strategy for asset diversification and financial, retirement, estate and tax planning activities over a period of time. In total, 50,000 options were exercised with 44,000 shares sold and 6,000 shares held by the reporting person.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $361.42 to $362.41, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $362.42 to $363.41, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $363.42 to $364.41, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $364.425 to $365.295, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $365.43 to $365.48, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
This option is fully vested.
Ryan Metz as Agent for Eric M. Green
2023-05-09